Spontaneous bacterial peritonitis;Peritonite bacteriana espontânea

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 36, Issue 6, 2003, Pages 711-717

  Strauss, Edna ^a,b   Caly, Wanda Regina ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Divisao de Anatomia Patologica   (Brazil)

Author keywords

Ascites; Bacteria; Cephalosporins; Cirrhosis; Peritonitis

Indexed keywords

CEPHALOSPORIN; NORFLOXACIN; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; ASCITES; ASCITES FLUID; BACTERIAL GROWTH; BACTERIAL OVERGROWTH; BACTERIAL PERITONITIS; EARLY DIAGNOSIS; GASTROINTESTINAL HEMORRHAGE; HOST RESISTANCE; HUMAN; LIVER CIRRHOSIS; MESENTERY LYMPH NODE; MORTALITY; PATHOGENESIS; PROPHYLAXIS; REVIEW;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 0742288877     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822003000600012     Document Type: Review

References (44)

1. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffig G, Reynolds TB, Ring-Larsen H, Scholmerich J. Definition and diagnosis criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 23:164-175, 1996.
2. Bac DJ. Spontaneous bacterial peritonitis: an indication for liver transplantation? Scandinavian Journal of Gastroenterolology 218 (suppl):38-42, 1996
3. Bernard B, Grange JD, Khac EN, Amiot X, Opolon P, Poynard T. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 29:1655-1661, 1999.
4. 2 microglobulin to discriminate functional renal failure from acute tubular damage. Gastroenterology 82:97-105, 1982.
5. Caly WR, Morais EM, Alencar RSSM, Ribeiro MFGS, Chehter EZ, Strauss E. Infusao de albumina na prevenção de insuficiência renal durante terapia da peritonite bacteriana espontânea: estudo de caso-controle. In: Anais da V Semana Brasileira do Aparelho Digestivo, Rio de Janeiro p.51, 2002.
6. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. Journal of Hepatology 18:353-358, 1993.
7. Conn HO, Atterbury, CE. Cirrhosis. In: Schiff L., Schiff E (eds). Diseases of the liver. Philadelphia, J.B. Lippincott 20:725-864, 1987.
8. Conn HO, Fessel JM. Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine 50:161-97, 1971.
9. Correia JP, Conn HO. Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? Medical Clinics of North America 59:936-81, 1975.
10. Felisart J, Rimola A, Arroyo V, Perez Ayuso RM, Quintero E, Gines P, Rodes J. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology 5: 457-62, 1985.
11. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. - Bacterial infections in cirrhosis; epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35:140-148, 2002
12. Garcia-Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology 120:726-748, 2001.
13. Ginés P, Rimola A, Planas R, Vargas V, Marco F, Almela M, Forne M, Miranda ML, Llach J, Salmeron JM, Esteve M, Marqués JM, Anta MTJ, Arroyo V, Rodés J. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo controlled trial. Hepatology 12:716-24, 1990.
14. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. - Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. Journal of Hepatology 26:1372-1378, 1997.
15. Guarner C, Sola R, Soriano G, Andrew M, Novella MT, Vila MC, Sabat M, Coll S, Ortiz J, Gomes C, Balanzo J. Risk of a first community acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 117:414-419, 1999.
16. Hoefs JC, Runyon BA. Spontaneous bacterial peritonitis. Hepatology 2:399-407, 1982.
17. Hsieh WJ, Hseh WJ, Lin HC, Hwang SJ, How MC, Lee FY, Chang FY, Lee SD. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. American Journal of Gastroenterology 93:962-965, 1998.
18. Kirchmair R, Allerberger F, Bangerl I, Egger C, Nachbaur K, Patsch JR, Vogel W. Spontaneous bacterial pleural empyema in liver cirrhosis. Digestive Disease and Science 43:1129-1132, 1998.
19. Llach J, Rimola A, Navasa M, Gines P, Salmeron JM, Gines A, Arroyo V, Rodes J. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascitis: relevance of ascitic fluid protein concentration. Hepatology 16:724-727, 1992.
20. Llovet JM, Planas R, Morillas R, Quer JC, Cabre E, Boix J, Humbert P, Guilera M, Domenech E, Bertran X, Gassull MA. Short-term prognosis of cirrhotics with spontaneous bacterial peritonitis: multivariate study. American Journal of Gastroenterology 88:388-92, 1992.
21. Madsen K, Cornihsh A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580-591, 2001.
22. Mattos AA. Peritonite bacteriana espontânea e suas variantes. Tese de Livre - Docência. Fundação Faculdade Federal de Ciências Médicas de Porto Alegre, 1992.
23. Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forne M, Planas R, Banares R, Castells L, Jimenez De Anta MT, Rodes J. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology 111:1011-1017, 1996.
24. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC), Gut 52:988-997, 2003.
25. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. Journal of Hepatology 32:142-153, 2000.
26. Rimola A, Salmeron JM, Clemente G, Rodrigo L, Obrador A, Miranda ML, Guarner C, Planas R, Sola R, Vargas V, Casafont F, Marco F, Navasa M, Banares R, Arroyo V, Rodes J. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study. Hepatology 21:674-679, 1995.
27. Rolando N, Harvey F, Brahm J, Philpott-Howard J, Alexander G, Gimson A, Casewell M, Fagan E, Williams R. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 11:49-53, 1990.
28. Runyon BA. Culture-negative neutrocytic ascites: a variant of spontaneous bacterial peritonitis. Hepatology 4:1209-1211, 1984.
29. Runyon BA. Monomicrobial non-neutrocytic bacterascites: a variant of spontaneous bacterial peritonitis. Hepatology 12:710-715, 1990.
30. Runyon BA, Akriviadis EA, Sattler FR, Cohen J. Ascitic fluid and serum cefotaxime and desacetyl cefotaxime levels in patients treated for bacterial peritonitis. Digestive Disease and Science 12:1782-1786, 1991.
31. Runyon BA, Antillon MR. Ascitic fluid pH and lactate: insensitive and nonspecific tests in detecting ascitic fluid infection. Hepatology 13: 929-935, 1991.
32. Runyon BA, Canawati HN, Akriviadis EA. Optimization of ascitic fluid culture technique. Gastroenterology 95:1351-1355, 1988.
33. Runyon BA, Mc Hutchison JG, Antillon MR, Akriviadis EA, Montano AA. Short-course versus long course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients. Gastroenterology 100:1737-1742, 1991.
34. Runyon BA, Squiers S, Borzio M. - Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. Journal of Hepatology 21:792-796, 1994.
35. Silvain C, Mannant R, Ingrand P, Fort E, Besson I, Beauchant M. Recidive de l'infection spontanée du liquide d'ascite au cours de la cirrhose. Gastroenterologie Clinique et Biologique 15:106-109, 1991.
36. Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, Villandell F. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 100:477-481, 1991.
37. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, Sainz S, Anguera A, Cusso X, Balanzo J, Vilardell F. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 103:1267-1272, 1992.
38. Sort P, Navasa M, Arroyo V, Aldegner X, Planas R, Ruiz del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Gines P, Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. New England Journal of Medicine 341:403-409, 1999.
39. Strauss E, Caly WR. Cirrose e Infecções Bacterianas. In: Gayotto LCC, Alves VAF (eds). Doenças do Fígado e Vias Biliares. Ed.Atheneu; 56:655-664, 2001.
40. Strauss E, Costa MF. The importance of bacterial infections as precipitating factors of chronic hepatic encephalopathy in cirrhosis. Hepato-Gastroenterology 45:900-904, 1998.
41. Strauss E, Ribeiro MFGS. Bacterial infections associated with hepatic encephalopathy: prevalence and outcome. Annals of Hepatology 2:41-45, 2003.
42. Terg R, Cobas S, Fassio E, Landeira G, Rios B, Vasen W, Abecasis R, Rios H, Guevara M. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study. Journal of Hepatology 33:564-569, 2000.
43. Titó L, Rimola A, Ginés P, Llach J, Arroyo V, Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 8:27-31, 1988.
44. Wilcox CM, Dismukes WE. Spontaneous bacterial peritonitis. A review of pathogenesis, diagnosis and treatment. Medicine 66: 447-456, 1987.